Li Enfu

Leaderna Therapeutics is a clinical-stage biotechnology company focused on the development of mRNA-based vaccines and therapeutics. Founded by Dr. Enfu Li, a veteran of the mRNA industry with experience at Moderna and BioNTech, the company utilizes proprietary lipid nanoparticle (LNP) delivery systems and mRNA design platforms. Its pipeline targets infectious diseases, including COVID-19 and shingles, as well as applications in oncology and rare diseases. Leaderna operates out of Suzhou, China, where it maintains integrated research, development, and manufacturing facilities to support its diverse portfolio of RNA medicines. The company is backed by prominent investors such as GL Ventures and Legend Capital, positioning it as a key player in the emerging Chinese mRNA sector.